Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development Molecular Approaches Toward Targeted Drug Development

This handbook is the first dealing with drug discovery for apicomplexan parasites. This group of endoparasites includes the infectious agent for Malaria, Toxoplasmosis and Babesiosis, the latter occurring mainly in animals. The title focuses on current approaches for drug development for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the pharmaceutical industry to veterinarian pharmaceutical industry. It is written by an international team of biologists, chemists and parasitologists from industry and academia underlining the cross-over appeal of the book. This Work is the second volume of our new series `Drug Discovery in Infectious Diseases?, edited by Paul Selzer.

This handbook deals with the discovery of drugs to fight apicomplexan parasites, a group of endoparasites that includes the causative agents of malaria, toxoplasmosis, and babesiosis, among others. Written by renowned scientific experts from academia and industry, the book focuses on current drug development approaches for all apicomplexan diseases, thus making it attractive to a large audience ranging from research labs in academia to the human and veterinarian pharmaceutical industry. This is the second volume in our exciting book series Drug Discovery in Infectious Diseases, edited by Prof. Paul M. Selzer.